Aflac Incorporated filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the three- and nine-month periods ended September 30, 2026, disclosing a sharp decline in quarterly net earnings driven by significant net investment losses.

Key Highlights

  • Net earnings fell to $303 million for the three months ended September 30, 2026, compared to $1,639 million in the same quarter of 2025, according to the filing.
  • Net investment losses of $1,072 million were recorded in Q3 2026, compared to gains of $275 million in Q3 2025, as the filing disclosed.
  • Net earned premiums totaled $3,304 million for the third quarter of 2026, down from $3,372 million in the prior-year quarter.
  • Diluted earnings per share were $0.61 for Q3 2026, versus $3.08 in Q3 2025, as reported in the filing.
  • Cash dividends per share were $0.61 for the quarter, up from $0.58 in the third quarter of 2025.
  • 494,607,060 shares of common stock were outstanding as of October 27, 2026, per the filing.
  • Total assets stood at $113,511 million as of September 30, 2026, down from $116,470 million at December 31, 2025.

Aflac's Third-Quarter 2026 Financial Results: Investment Losses Weigh on Earnings

According to the filing, Aflac Incorporated (NYSE:AFL) reported total revenues of $3,271 million for the three months ended September 30, 2026, a decline from $4,740 million in the same period of 2025. The company attributed the difference in large part to net investment losses of $1,072 million in Q3 2026, contrasting with net investment gains of $275 million in Q3 2025. Net earned premiums, described in the filing as "principally supplemental health insurance," declined to $3,304 million from $3,372 million year over year. Net investment income was $1,003 million in the quarter, compared with $1,067 million a year earlier.

For the nine months ended September 30, 2026, the filing reported net earnings of $2,147 million, compared to $2,267 million for the same period in 2025. Total revenues for the nine-month period were $11,734 million versus $12,298 million. Diluted earnings per share for the nine-month period were $4.24, compared to $4.21 in the prior-year period. Total benefits and claims, net of reserve remeasurement, were $5,123 million for the nine months ended September 30, 2026, against $5,391 million in the year-ago period.

On the balance sheet, the filing disclosed total assets of $113,511 million as of September 30, 2026, compared with $116,470 million at December 31, 2025. Fixed maturity securities available-for-sale declined to $56,949 million from $60,485 million over the same span. Total policy liabilities were $63,517 million, down from $69,583 million at year-end 2025. Notes payable and lease obligations increased to $8,900 million from $8,409 million. Other comprehensive income, net of income taxes, was a loss of $268 million for Q3 2026, compared with income of $1,144 million in Q3 2025, driven in part by unrealized holding losses on fixed maturity securities of $3,466 million before taxes in the quarter.

What Was Disclosed

Aflac's Form 10-Q for Q3 2026 reported a substantial year-over-year decline in quarterly net earnings and total revenues, primarily reflecting net investment losses. Total assets and policy liabilities also declined from year-end 2025 levels. Dividends per share rose modestly from Q3 2025.